280. Huge arteriovenous malformation with cervicofacial or limb lesion Clinical trials / Disease details
Clinical trials : 27 / Drugs : 30 - (DrugBank : 15) / Drug target genes : 14 - Drug target pathways : 153
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02625389 (ClinicalTrials.gov) | November 29, 2017 | 3/12/2015 | Evaluation of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization. | Safety and Efficacy of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization. A Phase IV Study. | Congenital Hemangioma;Hemangioendothelioma;Angiosarcoma;Arteriovenous Malformation | Drug: Lipiodol® Ultra Fluid with surgical glues | Guerbet | NULL | Recruiting | 18 Years | N/A | All | 125 | Phase 4 | India |